Report - 1 FDA ODAC Meeting November 8, 2005 Celecoxib (CELEBREX ® ) Therapy for Familial Adenomatous Polyposis (FAP) Subpart H Phase IV Commitments.

Select PornographicDefamatoryIllegal/UnlawfulSpamOther Terms Of Service ViolationFile a copyright complaint

Please pass captcha verification before submit form